07:00 , Apr 21, 2016 |  BC Innovations  |  Product R&D

A1M for preeclampsia

A poor understanding of disease biology and a challenging development pathway have kept most drug developers away from the serious pregnancy complication preeclampsia, but A1M Pharma AB has a new approach with a first-in-class therapy...
07:00 , Jun 8, 2015 |  BC Week In Review  |  Company News

Carmenta, Progenity deal

Progenity acquired Carmenta for an undisclosed sum. Carmenta is developing risk assessment and confirmatory diagnostic tests to detect preeclampsia. Progenity is a CLIA-accredited and CAP-certified laboratory specializing in women’s health and pediatric genetic testing. Carmenta...
07:00 , Oct 16, 2014 |  BC Innovations  |  Targets & Mechanisms

Alnylam interrupts preeclampsia

Preeclampsia often involves overactivation of the renin-angiotensin system that regulates blood pressure, but inhibiting the pathway is not possible because it would be toxic to the fetus. Alnylam Pharmaceuticals Inc. has developed an siRNA conjugate...
07:00 , Aug 18, 2014 |  BioCentury  |  Emerging Company Profile

GestVision: Urine for preeclampsia

The diagnosis of preeclampsia in pregnant women depends on assessing symptoms that do not reliably detect the disease, thereby delaying treatment decisions. GestVision Inc. 's test uses urine markers to rapidly detect preeclampsia at the...
07:00 , Aug 7, 2014 |  BC Innovations  |  Cover Story

Dyeing to diagnose preeclampsia

Although there is widespread agreement on the need for a better way to diagnose preeclampsia, few companies have pursued new tests because finding specific markers has been difficult. A Yale-led group has found dye-binding aggregates...
07:00 , Aug 7, 2014 |  BC Innovations  |  Distillery Techniques

Technology: Assays & screens

Approach Summary Licensing status Publication and contact information Assays & screens Preeclampsia diagnostic based on amyloid oligomer content of urine A method for detecting amyloid oligomer content in urine could help diagnose preeclampsia. Urine from...
07:00 , Mar 27, 2014 |  BC Innovations  |  Strategy

Teaching translation

Efforts of university technology transfer offices to find the optimal path for commercializing discoveries have been well documented, 1-3 but the offices are not set up to implement translational research directly. Indeed, a growing number...
07:00 , Sep 23, 2013 |  BioCentury  |  Emerging Company Profile

Carmenta: Preempting preeclampsia

The diagnosis of preeclampsia in pregnant women currently relies on detection of symptoms that do not reliably differentiate it from other conditions, thereby delaying treatment decisions. Carmenta Bioscience Inc. 's panel of serum markers could...
07:00 , Aug 12, 2013 |  BC Week In Review  |  Company News

Carmenta board of directors update

Carmenta BioScience Inc. , Palo Alto, Calif.   Business: Diagnostic   Appointed: Camille Samuels  ...
07:00 , Aug 12, 2013 |  BC Week In Review  |  Financial News

Carmenta completes venture financing

Carmenta Bioscience Inc. , Palo Alto, Calif.   Business: Diagnostic   Date completed: 8/8/13   Type: Venture financing   Raised: $2 million  ...